No company release dated October 13 was found in company filings and wire releases reviewed, so the most relevant recent updates are summarized here. LENZ Therapeutics sells VIZZ, the first aceclidine eye drop for presbyopia, and reported second-quarter 2026 revenue of USD 5.5 million, …
No company release dated October 13 was found in company filings and wire releases reviewed, so the most relevant recent updates are summarized here. Intellia Therapeutics, a CRISPR gene editing company, fell 4.97% to USD 11.95 on volume of 13.954 million shares, about 3.4 …
No company release dated October 13 was found in company filings and wire releases reviewed, so the most relevant recent updates are summarized here. Novavax reported second-quarter 2026 total revenue of USD 57 million, down 76% from USD 239 million a year earlier, when …
No company release dated October 13 was found in company filings and wire releases reviewed, so the most relevant recent updates are summarized here. Recursion, an AI-driven drug discovery company, fell 3.99% to USD 3.85 on volume of 30.79 million shares, 1.5 times its …
Scinai Immunotherapeutics, a Jerusalem biopharma that also runs a contract development and manufacturing business, announced on October 13 that Scinai Biopharma Services signed a definitive agreement worth about USD 5.1 million in committed base fees for chemistry, manufacturing and controls development and clinical manufacturing …
No company release dated October 13 was found in company filings and wire releases reviewed, so the most relevant recent updates are summarized here. Tenon Medical is a medical device company whose Catamaran system treats sacroiliac joint dysfunction, and it fell 2.01% to USD …
Bristol Myers Squibb (NYSE:BMY) fell USD 0.95 to USD 56.63 on 12.927 million shares, about 1.2 times its 3-month average of 11.217 million. The news was positive but mixed: the Phase 3 trial of admilparant in idiopathic pulmonary fibrosis met its primary endpoint at …
No company release dated October 13 was found in company filings and wire releases reviewed, so the most relevant recent updates are summarized here. China Pharma Holdings is a Haikou-based specialty pharmaceutical company with eight GMP-certified product lines, listed on NYSE American. NYSE American …
Hyperfine, maker of the Swoop portable MRI brain imaging system, issued a preliminary third-quarter 2026 update showing revenue of about USD 6.0 million, up roughly 53% sequentially and about 55% year over year, and net cash burn of about USD 5.6 million, down about …
No company release dated October 13 was found in company filings and wire releases reviewed, so the most relevant recent updates are summarized here. DataMeds AI, a Tampa-based health IT company that changed its name from Wellgistics Health in July and began trading as …